Antineoplastic agents, traditional
Aus coViki
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „cyclophosphamide see Immunosuppressants '''Anti Neoplastic agents''' {{tp|p=32398164|t=2020. Drug repurposing against COVID-19: focus on anticancer agent…“) |
K |
||
| (Eine dazwischenliegende Version von einem Benutzer wird nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
| + | {{up|PHA conventional pharmacology}} | ||
| + | |||
cyclophosphamide see [[Immunosuppressants]] | cyclophosphamide see [[Immunosuppressants]] | ||
| Zeile 11: | Zeile 13: | ||
'''Etoposide''' | '''Etoposide''' | ||
{{tp|p=32416415|t=2020. Etoposide-based therapy for severe forms of COVID-19.|pdf=|usr=009}} | {{tp|p=32416415|t=2020. Etoposide-based therapy for severe forms of COVID-19.|pdf=|usr=009}} | ||
| + | {{tp|p=32579985|t=2020. Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients: Etoposide for severe COVID-19 patients.|pdf=|usr=011}} | ||
Aktuelle Version vom 18. Januar 2021, 20:26 Uhr
| PHA conventional pharmacology |
cyclophosphamide see Immunosuppressants
Anti Neoplastic agents
32398164 2020. Drug repurposing against COVID-19: focus on anticancer agents.
5-Fluorouracil 5-FU
32438240 2020. 5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection
Etoposide
32416415 2020. Etoposide-based therapy for severe forms of COVID-19.
32579985 2020. Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients: Etoposide for severe COVID-19 patients.
